Covered recipient · General Payments record
WAEL K BERJAOUI
Allopathic & Osteopathic Physicians Internal Medicine Critical Care Medicine
General Payments · PY2018–2024
$1,339.67
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $229.38 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABIOMED | $65.33 | 3 |
| United Therapeutics Corporation | $42.22 | 1 |
| Mylan Specialty L.P. | $35.31 | 2 |
| GENZYME CORPORATION | $27.64 | 1 |
| Acerta Pharma LLC | $22.68 | 1 |
| Merck Sharp & Dohme Corporation | $20.48 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $15.72 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $18.62 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142293549 | CMS |
| ABIOMED | $27.50 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142293425 | CMS |
| ABIOMED | $19.21 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142293603 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.68 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105588282 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $15.72 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086188580 | CMS |
| GENZYME CORPORATION | $27.64 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139969037 | CMS |
| Merck Sharp & Dohme LLC | $20.48 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141565827 | CMS |
| Mylan Specialty L.P. | $20.40 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147294129 | CMS |
| Mylan Specialty L.P. | $14.91 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147323388 | CMS |
| United Therapeutics Corporation | $42.22 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149468526 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.